Stage-specific innate immune recognition of Aspergillus fumigatus and modulation by echinocandrin drugs

Medical Mycology

Volumn 47, Issue SUPPL. 1, 2009, Pages

  Hohl, Tobias M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Aspergillus; Dectin; Echinocandin; Fungus; Innate immunity; Toll like receptor

Indexed keywords

1,3 BETA GLUCAN SYNTHASE; BETA 1,3 GLUCAN; CASPOFUNGIN; CXCL2 CHEMOKINE; DECTIN 1; ECHINOCANDIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; BETA GLUCAN; BETA-1,3-GLUCAN; CLEC7A PROTEIN, HUMAN; IMMUNOLOGIC FACTOR; LECTIN;

ANTIGEN RECOGNITION; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CELL WALL; CONIDIUM; CYTOKINE PRODUCTION; FUNGAL SPORE GERMINATION; FUNGUS HYPHAE; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NEUTROPHIL; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ASPERGILLOSIS; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; FUNGI;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BETA-GLUCANS; ECHINOCANDINS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; LECTINS, C-TYPE;

EID: 68449102368     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802078131     Document Type: Article

References (60)

1. Pamer EG. Immune responses to commensal and environmental microbes. Nat Immunol 2007; 8: 1173-1178.
2. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-350.
3. Hohl TM, Feldmesser M. Aspergillus fumigatus: Principles of pathogenesis and host defense. Eukaryot Cell 2007; 6: 1953-1963.
4. Barnes PD, Marr KA. Aspergillosis: Spectrum of disease, diagnosis, and treatment. Infect Dis Clin North Am 2006; 20: 545-561.
5. Bellocchio S, Montagnoli C, Bozza S, et al. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172: 3059-3069.
6. Cenci E, Perito S, Enssle KH, et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 1997; 65: 564-570.
7. Bonnett CR, Cornish EJ, Harmsen AG, Burritt JB. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus conidia. Infect Immun 2006; 74: 6528-6539.
8. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982; 69: 617-631.
9. Zarember KA, Sugui JA, Chang YC, et al. Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. J Immunol 2007; 178: 6367-6373.
10. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007; 204: 793-804.
11. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 1997; 185: 207-218.
12. Philippe B, Ibrahim-Granet O, Prevost MC, et al. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 2003; 71: 3034-3042.
13. Tkalcevic J, Novelli M, Phylactides M, et al. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 2000; 12: 201-210.
14. Hohl TM, Van Epps HL, Rivera A, et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog 2005; 1: E30.
15. Gersuk GM, Underhill DM, Zhu L, Marr KA. Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol 2006; 176: 3717-3724.
16. Latge JP. The cell wall: A carbohydrate armour for the fungal cell. Mol Microbiol 2007; 66: 279-290.
17. Steele C, Rapaka RR, Metz A, et al. The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus PLoS Pathog 2005; 1: E42.
18. Brown GD. Dectin-1: A signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 2006; 6: 33-43.
19. West AP, Koblansky AA, Ghosh S. Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 2006; 22: 409-437.
20. Luther K, Ebel F. Toll-like receptors: Recent advances, open questions and implications for aspergillosis control. Med Mycol 2006; 44 S219-S227.
21. Ikeda Y, Adachi Y, Ishii T, et al. Dissociation of Toll-like receptor 2-mediated innate immune response to Zymosan by organic solvent-treatment without loss of Dectin-1 reactivity. Biol Pharm Bull 2008; 31: 13-18.
22. Balloy V, Si-Tahar M, Takeuchi O, et al. Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73: 5420-5425.
23. Dubourdeau M, Athman R, Balloy V, et al. Aspergillus fumigatus induces innate immune responses in alveolar macrophages through the MAPK pathway independently of TLR2 and TLR4. J Immunol 2006; 177: 3994-4001.
24. Bretz C, Gersuk G, Knoblaugh S, et al. Myd88-signaling contributes to early pulmonary responses to Aspergillus fumigatus. Infect Immun 2008; 76: 952-958.
25. Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 2005; 24: 1277-1286.
26. Steele C, Marrero L, Swain S, et al. Alveolar macrophagemediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J Exp Med 2003; 198: 1677-1688.
27. Viriyakosol S, Fierer J, Brown GD, Kirkland TN. Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1. Infect Immun 2005; 73: 1553-1560.
28. Rappleye CA, Eissenberg LG, Goldman WE. Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor. Proc Natl Acad Sci USA 2007; 104: 1366-1370.
29. Netea MG, Gow NA, Munro CA, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 2006; 116: 1642-1650.
30. Taylor PR, Tsoni SV, Willment JA, et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 2007; 8: 31-38.
31. Saijo S, Fujikado N, Furuta T, et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 2007; 8: 39-46.
32. Gross O, Gewies A, Finger K, et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 2006; 442: 651-656.
33. Luther K, Torosantucci A, Brakhage AA, Heesemann J, Ebel F. Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cell Microbiol 2007; 9: 368-381.
34. Wheeler RT, Fink GR. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog 2006; 2: E35.
35. Douglas CM. Understanding the microbiology of the Aspergillus cell wall and the efficacy of caspofungin. Med Mycol 2006; 44: S95-S99.
36. Deresinski SC, Stevens DA. Caspofungin. Clin Infect Dis 2003; 36: 1445-1457.
37. Hope WW, Shoham S, Walsh TJ. The pharmacology and clinical use of caspofungin. Expert Opin Drug Metab Toxicol 2007; 3: 263-274.
38. Kurtz MB, Heath IB, Marrinan J, et al. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase. Antimicrob Agents Chemother 1994; 38: 1480-1489.
39. Bowman JC, Hicks PS, Kurtz MB, et al. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob Agents Chemother 2002; 46: 3001-3012.
40. Bartizal K, Gill CJ, Abruzzo GK, et al. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743, 872). Antimicrob Agents Chemother 1997; 41: 2326-2332.
41. Abruzzo GK, Flattery AM, Gill CJ, et al. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother 1997; 41: 2333-2338.
42. Abruzzo GK, Gill CJ, Flattery AM, et al. Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice. Antimicrob Agents Chemother 2000; 44: 2310-2318.
43. Wiederhold NP, Kontoyiannis DP, Chi J, et al. Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. J Infect Dis 2004; 190: 1464-1471.
44. Petraitiene R, Petraitis V, Groll AH, et al. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: Pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Antimicrob Agents Chemother 2002; 46: 12-23.
45. Chiller T, Farrokhshad K, Brummer E, Stevens DA. The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity against Aspergillus fumigatus. Diagn Microbiol Infect Dis 2001; 39: 99-103.
46. Beauvais A, Bruneau JM, Mol PC, et al. Glucan synthase complex of Aspergillus fumigatus. J Bacteriol 2001; 183: 2273-2279.
47. Hohl TM, Feldmesser M, Perlin DS, Pamer EG. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis (in press).
48. Lamaris GA, Lewis RE, Chamilos G, et al. Caspofunginmediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis (in press).
49. Kahn JN, Hsu MJ, Racine F, Giacobbe R, Motyl M. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: Inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in culture. Antimicrob Agents Chemother 2006; 50: 2214-2216.
50. Pfaller MA, Marco F, Messer SA, Jones RN. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743, 792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis 1998; 30: 251-255.
51. Mouyna I, Morelle W, Vai M, et al. Deletion of GEL2 encoding for a beta(1-3)glucanosyltransferase affects morphogenesis and virulence in Aspergillus fumigatus. Mol Microbiol 2005; 56: 1675-1688.
52. Fontaine T, Hartland RP, Beauvais A, Diaquin M, Latge JP. Purification and characterization of an endo-1,3-beta-glucanase from Aspergillus fumigatus. Eur J Biochem 1997; 243: 315-321.
53. Fontaine T, Hartland RP, Diaquin M, et al. Differential patterns of activity displayed by two exo-beta-1,3-glucanases associated with the Aspergillus fumigatus cell wall. J Bacteriol 1997; 179 3154-3163.
54. Sau K, Mambula SS, Latz E, et al. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem 2003; 278: 37561-37568.
55. Lewis RE, Chamilos G, Prince RA, Kontoyiannis DP. Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice. Antimicrob Agents Chemother 2007; 51: 1078-1081.
56. Willment JA, Lin HH, Reid DM, et al. Dectin-1 expression and function are enhanced on alternatively activated and GM-CSFtreated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J Immunol 2003; 171: 4569-4573.
57. Brummer E, Kamberi M, Stevens DA. Regulation by granulocytemacrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia. J Infect Dis 2003; 187: 705-709.
58. Balloy V, Huerre M, Latge JP, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73: 494-503.
59. Stephens-Romero SD, Mednick AJ, Feldmesser M. The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun 2005; 73: 114-125.
60. Stergiopoulou T, Meletiadis J, Roilides E, et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Path 2007; 127: 349-355.